It’s a pretty poor system if you spend a year and a half preparing a resubmission, just for the FDA to set you back another 12 months. Why is it like an exam you study for where you need to get 100% and not a feedback process? If your product meets the safety data end point, it should not be judged by a 100% test result.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.020(1.92%) |
Mkt cap ! $113.3M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.05 | $1.02 | $220.9K | 213.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9803 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 49222 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| CYC (ASX) Chart |